Rita Fragoso

1.1k citations
17 papers · 654 indexed · h-index 13
Topics
Acute Lymphoblastic Leukemia research (4 papers)Angiogenesis and VEGF in Cancer (4 papers)Acute Myeloid Leukemia Research (2 papers)

In The Last Decade

Rita Fragoso

16 papers receiving 650 citations

Peers

Rita Fragoso
Comparison fields: 5 of 78
  • Molecular Biology 387
  • Cancer Research 231
  • Immunology 167
  • Oncology 126
  • Hematology 106
Replace Margherita Ghisi with:
Margherita Ghisi Australia
María Jesús García-León Spain
Elena Federzoni Switzerland
Klaus Fortschegger Austria
Eigo Shimizu Japan
Kim L. Rice United States
Hind Medyouf Germany
Huacheng Luo United States
Ageliki Tsagaratou United States
Parvathi Ranganathan United States
Rita Fragoso relative to Margherita Ghisi Australia Margherita Ghisi's profile →
Citations per field
00.5×1.7×
Margherita Ghisi · 1×
Citations per year

Countries citing papers authored by Rita Fragoso

Since Specialization
Citations

This map shows the geographic impact of Rita Fragoso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Fragoso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Fragoso more than expected).

Fields of papers citing papers by Rita Fragoso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Fragoso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Fragoso. The network helps show where Rita Fragoso may publish in the future.

Co-authorship network of co-authors of Rita Fragoso

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Fragoso. A scholar is included among the top collaborators of Rita Fragoso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Fragoso. Rita Fragoso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 45
3 16
4 29
5 23
6 36
7 66
8 30
9 132
10 103
11 40
12 7
13 29
14 22
15 1
16 70
17
Molecular characterization of the fragile-X syndrome in the Mexican population.
5

About Rita Fragoso

Rita Fragoso is a scholar working on Hematology, Cancer Research and Physiology, having authored 17 papers that have together received 654 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cancer Research (231 citations), Hematology (106 citations) and Immunology (167 citations). Rita Fragoso has collaborated with scholars based in Portugal, United States and Brazil. Frequent co-authors include João T. Barata, Steven Schaffert, Chang‐Zheng Chen, Christina Loh, Sérgio Dias, Tânia Carvalho, Yan Wu, Zhenping Zhu, Teresa Pereira and José Cabeçadas. Their work appears in journals such as Blood, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026